Abstract: Systems, devices, methods and computer program products for extendable conveyors are provided. A system includes an extendable conveyor and a separation module. The extendable conveyor is operable to convey items from an upstream side of the extendable conveyor to a downstream side of the extendable conveyor. Further, it is configured to increase the distance from the upstream side to the downstream side. The separation module is operable for conveying items towards the extendable conveyor and configured to decelerate the conveying of the items on the separation module.

Abstract: An expansion valve (1) is described to include a housing (2) having in inlet port (3) and an outlet port (4), a valve seat (5) arranged between the inlet port (3) and the outlet port (4), a valve element (6) movable over an operating stroke between a closed position at the valve seat (5) and an opened position away from the valve seat (5), and an actuator (7), wherein the actuator (7) has an electric rotary motor (8) acting on the valve element (5) by means of a threaded spindle (10) and a nut (9), wherein one of spindle (10) and nut (9) is rotatably driven by the motor (8) and the other one is rotatably fixed. Such an expansion valve should have the possibility for a simple assembly. To this end, in a disassembled condition of housing (2) and actuator (7), the actuator (7) has a mounting stroke which is at least two times the operating stroke, wherein the mounting stoke extends the operating stroke.

Abstract: A compound of formula (I) for use in a method for treatment of pulmonary fibrosis in a human including administering, with a dry powder inhaler, once-a-day to the narrowest parts of the lung tissue of the human an amount of the compound of formula (I) effective to treat the pulmonary fibrosis.

Abstract: The present invention relates to a compound of formula (I) for use in a method for treatment of pulmonary fibrosis in a human including administering once-a-day to the narrowest parts of the lung tissue of the human an amount of the compound of formula (I) effective to treat said pulmonary fibrosis.

Abstract: Systems, devices, methods and computer program products for extendable conveyors are provided. A system includes an extendable conveyor and a separation module. The extendable conveyor is operable to convey items from an upstream side of the extendable conveyor to a downstream side of the extendable conveyor. Further, it is configured to increase the distance from the upstream side to the downstream side. The separation module is operable for conveying items towards the extendable conveyor and configured to decelerate the conveying of the items on the separation module.

Abstract: A stabilized amorphous form of a compound of formula I as well as compositions for oral administration including the compound of formula I in a therapeutically effective amount. Also, methods for treatment of a disease or disorder in which therapeutically effective amount of a composition including a compound of formula I is administered to a subject in need thereof.

Abstract: A valve arrangement comprising a valve housing, a valve inlet, a valve outlet and a diaphragm assembly for controlling a fluid flow through the valve housing from the valve inlet to the valve outlet, the diaphragm assembly comprising a diaphragm and a diaphragm plate at least partially covering the diaphragm, the diaphragm comprising one or more equalization holes passing through the diaphragm and the diaphragm plate comprising one or more equalization openings passing through the diaphragm plate, the equalization holes being aligned with the equalization openings. The diaphragm assembly comprises an engagement zone engaging the diaphragm in order to rotationally fix the diaphragm and the diaphragm plate with respect to each other so that the equalization holes will keep aligned with the equalization openings to ensure proper function of the valve arrangement at all times.

Abstract: A process for preparing an amorphous form of a compound of formula (I) This amorphous compound I is particularly suitable in treating IPF by pulmonary administration.

Abstract: The invention relates to a valve (1) comprising a main valve (2), a pilot valve (3), a housing (4), an inlet (5) and an outlet (8). Opening and closing of the main valve (2) is controlled by the pilot valve (3). A pilot valve seat (10) is arranged in a diaphragm (6). A pilot chamber (11) is arranged in the housing (4) separated from the inlet (5) and the outlet (8) by the diaphragm (6). Task of the invention is to provide a valve with a lower cost. According to the invention a support member (17) supports the diaphragm (6), wherein the support member (17) is guided in the housing, and wherein a radial gap (26) is arranged between the radially outer end of the diaphragm (6) and the housing (4) in a radial direction perpendicular to the opening direction of the pilot valve (3). Thereby, a cheaper, less resistant material for the diaphragm can be used.

Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: A process for preparing an amorphous form of a compound of formula (I) This amorphous compound I is particularly suitable in treating IPF by pulmonary administration.

Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Abstract: The present invention relates to a valve arrangement (1) comprising a valve housing (2), a valve inlet (3), a valve outlet (4) and a diaphragm assembly for controlling a fluid flow through the valve housing (2) from the valve inlet (3) to the valve outlet (4), the diaphragm assembly comprising a diaphragm (5) and a diaphragm plate (6) at least partially covering the diaphragm (5), the diaphragm (5) comprising one or more equalization holes (13) passing through the diaphragm (5) and the diaphragm plate (6) comprising one or more equalization openings (12) passing through the diaphragm plate (6), the equalization holes (13) being aligned with the equalization openings (12). According to the invention, the diaphragm assembly comprises an engagement zone engaging the diaphragm (5) in order to rotationally fix the diaphragm (5) and the diaphragm plate (6) with respect to each other. This has the effect that the equalization holes (13) will keep aligned with the equalization openings (12).

Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: The invention relates to a valve (1) comprising a main valve (2), a pilot valve (3), a housing (4), an inlet (5) and an outlet (8). Opening and closing of the main valve (2) is controlled by the pilot valve (3). A pilot valve seat (10) is arranged in a diaphragm (6). A pilot chamber (11) is arranged in the housing (4) separated from the inlet (5) and the outlet (8) by the diaphragm (6). Task of the invention is to provide a valve with a lower cost. According to the invention a support member (17) supports the diaphragm (6), wherein the support member (17) is guided in the housing, and wherein a radial gap (26) is arranged between the radially outer end of the diaphragm (6) and the housing (4) in a radial direction perpendicular to the opening direction of the pilot valve (3). Thereby, a cheaper, less resistant material for the diaphragm can be used.

Abstract: The present invention relates to a compound of formula (I) for use in a method for treatment of pulmonary fibrosis in a human including administering once-a-day to the narrowest parts of the lung tissue of the human an amount of the compound of formula (I) effective to treat said pulmonary fibrosis.

Abstract: The invention relates to a solenoid valve with a housing as well as an inlet and an outlet, wherein the solenoid valve further comprises a valve element and an orifice, wherein the orifice comprises an orifice inlet and an orifice outlet. In order to increase the maximum operating pressure differential of the solenoid valve the orifice is provided in a membrane and the orifice has a diffuser characteristic in a direction from the orifice inlet to the orifice outlet.